We create oncolytic viruses with unprecedented selectivity and efficiency.
Using our platform we engineer therapeutics with unprecedented selectivity and efficiency over traditional treatments.
Artificial virus platform
Our “digital first” approach to designing therapeutics ensures safety and efficacy in targeted cancer treatment. We are building a library of verified and reusable components
Viruses are designed on a computer using our library of verified genetic sequences and virus features.
Code is synthesized into sequence perfect fragments. This reliability cuts steps and time that are required by the previous methods like CRISPR.
We assemble the DNA and make the viruses. We test the viruses.
Our cancer therapies have the following characteristics:
- Highly selective – to only target and kill cancer cells
- Regulate Immune Response – to enhance therapeutic effects
- Penetrate physical barriers – to break down solid tumors
- Systematic delivery – to treat primary tumor and metastases
We are actively looking for clinical and scientific collaborators. Partner with us: firstname.lastname@example.org